After a day of swirling rumors and anonymous leaks, the Russian newspaper RBC reported that the star of the Russian figure skating squad, 15-year-old Kamila Valieva, tested positive for a banned substance.
The AP, citing the Russian newspaper, reported that Valieva—the gold-medal favorite who just days before became the first woman to land a quadruple jump in the Olympics—apparently tested positive before the Beijing Games, and even before the European Championships in January. International athletes are tested randomly at any time, both during and outside of competitions. Valieva reportedly tested positive for the drug trimetazidine, which is a heart medication generally prescribed to patients with angina to maintain blood flow and prevent blockages that can stop the heart. It can also reduce inflammation and relax blood vessels, and helps people who have had stents or heart operations to maintain the steady flow of blood from the heart to the rest of the body.
[time-brightcove not-tgx=”true”]
Contents
Trimetazidine’s history in doping
The drug has had a darker history in recent years, however, as a doping agent by athletes looking for an extra edge in endurance, whether for training or for competition.
Since 2014, the World Anti-Doping Agency has listed trimetazidine as a metabolic modulator for that reason, since it can give athletes an unfair chemical advantage. Chinese swimmer Sun Yang served a three-month ban in 2014 after testing positive for the drug, while Russian bobsledder Nadezhda Sergeeva was disqualified from the 2018 Olympics and served an eight-month ban for the same drug.
It’s unclear whether Valieva has a heart condition or has another reason for legitimately using the drug. If either is the case, she would also have had to receive a special dispensation or medical allowance to use the medication.
What happens next after Valieva’s reported positive drug test
The medal ceremony for the team figure skating event, scheduled for Feb. 8 in Beijing, was…
Source : time
